[267 Pages Report] The global blood collection devices market is projected to reach USD 6.4 billion by 2025 from USD 4.8 billion in 2020, at a CAGR of 6.0% between 2020 and 2025. The major factors driving the growth of this market include the increasing incidence of infectious diseases, the rising number of accidents & trauma cases, the emergence of liquid biopsy tests, and a demand for blood donations and blood components.

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the global BLOOD COLLECTION DEVICES market

The COVID-19 outbreak is an unprecedented global public health challenge and is expected to have a significant impact on the blood collection devices market.

Both hospital and independent laboratories are generally reviewing each test to decide whether to recommend consultations with laboratory hematologists for tests with a higher risk profile or not offer tests that could not be performed safely. This affected the market negatively in the first few months of the pandemic, reducing the use of blood collection devices. However, increasing caution and the rising testing volumes, along with the need for regular health and body checkups will ensure market growth in a later phase.

Results now take an average of four to six days for the general population, much longer than the two to three days required before. This is because tests for hospital patients and symptomatic healthcare workers are prioritized and take one day on average, which has resulted in a delayed cycle. While it has affected market growth to some extent, the situation is expected to change for the better.

BLOOD COLLECTION DEVICES Market Dynamics

Driver: Increasing chronic & lifestyle diseases

The burden of chronic diseases is rapidly increasing worldwide. Almost half of the total chronic disease deaths are attributable to cardiovascular disease (CVD). In the US alone, as per the American Heart Association, the prevalence of CVD is projected to increase from 36.9% in 2010 to 38.7% by 2020 and 40.5% by 2030. Obesity and diabetes are also showing worrying trends, not only because they already affect a large proportion of the population but also because they have started to appear earlier in life. The prevalence of lifestyle diseases is also growing across the globe, and particularly in emerging countries.

This scenario has ensured greater adherence to health checkups and the growing importance of markers to find disease conditions mainly via blood collection. Health checkups are gaining popularity both at a personal level as well as performed at a corporate level for employee well-being. This will be favorable for the market growth and a significant contributor to the blood collection devices market, as blood tests are a primary mode of diagnosing these diseases.

Restraint : High cost of automated blood collection devices

For blood banks, capital investments in automated blood collection using apheresis devices are very high in comparison to that of whole-blood collection. The average price for devices ranges between USD 45,000 and USD 55,000. Hence, smaller blood banks and hospitals do not opt for this type of blood collection. The cost of therapeutic apheresis is also very high, as it includes the additional cost of disposables�between USD 1,500 and USD 3,000 per patient. Owing to their high costs, the adoption of these automated blood collection products is very low as compared to manual blood collection products in countries such as China and India. This is limiting the overall growth of the blood collection devices market.

The cost of providing apheresis therapy is a matter of almost universal concern. Estimates of costs of individual apheresis treatments are very much available but vary widely. For instance, in the US, the cost of an apheresis procedure is approximately USD 2,500 per treatment. An investment of USD 19,000 to USD 32,000 for a blood cell separator is the initial cost for setting up the machine, and disposable sets produced by manufacturers will vary between USD 40 and USD 90 per treatment. Replacement fluids (at an average volume of 2.8 liters), such as albumin or fresh frozen plasma, make up the remainder of the costs, running USD 125 to USD 600 per treatment

Challenge: Complexities of storage and shipping

Storing and shipping whole blood samples poses significant challenges and costs. Once collected, whole blood must be used immediately or stored and maintained under strict temperature and environmental conditions for analysis or other applications. The characteristics of blood samples begin to change within hours of collection if not refrigerated or frozen. Maintaining their stability is essential since blood components begin to degrade immediately; extended exposure to ambient temperatures can dramatically affect the outcome of any analysis on such samples. Therefore, medical organizations around the world have created guidelines for their storage, packaging, and shipping.

For example, the US FDA recommends that whole blood samples held in specialized containers should only be kept refrigerated for 42 days. However, it is recognized that some changes in the samples may occur during that time. Another governing body, the National Institute of Health and Welfare in Finland, determined that whole blood samples refrigerated at 4� C (or about 39� F) should only be held for up to seven days before discarding.

Opportunity: Technological advancements in blood collection procedures and products

Collecting blood samples from patients with difficult venous access (DVA) is challenging or sometimes impossible. In DVA patients, traditionally used blood collection products are often unable to collect adequate samples, which can also lead to repeated attempts to collect blood. This increases the risk of anemia in patients and the risk of transmission of blood-borne pathogens to nurses and phlebotomists.

To overcome this issue, innovative hematology-tube designs have been introduced to support capillary-blood collection for reducing the risks of collection and processing errors in DVA patients. Besides this, a vein illumination and visualization technique�vein finder, a recent addition to safe blood collection procedures�is used to assist healthcare professionals in finding a good vein for venipuncture. The device illuminates the veins beneath the skin using ultrasound or infrared technology and facilitates easy vein access, thus reducing the need for repeated venipuncture.

There is a growing trend toward innovations in blood collection. Two firms won US FDA 510(k) clearances for blood collection devices recently�a push-button device from Seventh Sense called TAP, and a needle-free device from Velano Vascular called Pivo. Meanwhile, other firms, such as Neoteryx, are pursuing microsampling of blood but focusing on dried blood spots.

�Hospitals, ASCs, & Nursing homesaccounted for the largest market share in 2019�

In 2019, the hospitals, ASCs, & nursing homes segment accounted for the largest share of the blood collection devices market. Growth in this market segment can be attributed to the increasing incidence of infectious diseases and the rise in the number of trauma cases, as well as C-sections and organ transplants, have ensured the demand for blood collection equipment and devices in hospital facilities.

Clinical laboratories dominated the blood collection devices market in 2019

On the basis of end user, the blood collection devices market is segmented into hospitals, ASCs, & nursing homes, blood banks, diagnostic & pathology laboratories, and other end users. In 2019, the hospitals, ASCs, & nursing homes segment accounted for the largest share of the blood collection devices market.

North America accounted for the largest share of the global blood collection devicesmarket in 2019.

North America (comprising the US and Canada) accounted for the largest share of the global blood collection devices market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders, better healthcare facilities, and the presence of major manufacturers in the region are stimulating the growth of the blood collection devices market in North America.

To know about the assumptions considered for the study, download the pdf brochure

Some of the key players include Becton, Dickinson and Company (US), , Haematonics (US), Terumo BCT (Japan), Fresenius Kabi AG (Germany), Grifols (Spain), Nipro Medical Corporation (Japan), Greiner Holding (Austria), Quest Diagnostics (US), SARSTEDT AG & Co. (Germany), Macopharma (France), Smiths Medical (US), Kawasumi Laboratories (Japan), Retractable Technologies (US), LiuyangSanli Medical Technology Development (China), F.L. Medical S.R.L (Italy), AB Medical (South Korea), APTCA SPA (Italy), MicsafeMedical Group Limited (China), DiseraTibbiMalzemeLojistik Sanayi VeTicaret A.� (Turkey), Ajosha Bio Teknik Pvt. Ltd. (India), Preq Systems (India), CML Biotech (India), LmbTechnologie GmbH (Germany), Mitra Industries Private Limited (India) and Neomedic Limited (UK).

Report Metric Details Market Size Available for Years 2017�2025 Base Year Considered 2019 Forecast Period 2020�2025 Forecast Units Value (USD) Segments Covered Method, Product, Application, End User, and Region Geographies Covered North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa Companies Covered Becton, Dickinson and Company (US), , Haematonics (US), Terumo BCT (Japan), Fresenius Kabi AG (Germany), Grifols (Spain), Nipro Medical Corporation (Japan), Greiner Holding (Austria), Quest Diagnostics (US), SARSTEDT AG & Co. (Germany), Macopharma (France), Smiths Medical (US), Kawasumi Laboratories (Japan), Retractable Technologies (US), LiuyangSanli Medical Technology Development (China), F.L. Medical S.R.L (Italy), AB Medical (South Korea), APTCA SPA (Italy), Micsafe Medical Group Limited (China), DiseraTibbiMalzemeLojistik Sanayi VeTicaret A.� (Turkey), Ajosha Bio Teknik Pvt. Ltd. (India), Preq Systems (India), CML Biotech (India), LmbTechnologie GmbH (Germany), Mitra Industries Private Limited (India) and Neomedic Limited (UK)

This research report categorizes the blood collection devices market into the following segments:

Blood collection devices Market, by Product

Blood Collection tubes

Plasma/whole-blood tubes

EDTA Tubes

Heparin Tubes

Coagulation Tubes

Glucose Tubes

ESR Tubes

Serum Tubes

System Type

Vacuum Tubes

Non-vacuum Tubes

Needles & Syringes

Blood Bags

Blood Collection Systems/Monitors

Lancets

Blood collection devices Market, by Application

Diagnostics

Therapeutics

Blood collection devices Market, by Method

Manual Blood Collection

Automated Blood Collection

Blood collection devices Market, by End User

Hospitals, Ambulatory Surgical Centers, & Nursing Homes

Diagnostic & Pathology Laboratories

Blood Banks

Other End Users

Blood collection devices Market, by Region

North America US Canada

Europe Germany UK France Italy Spain Rest of Europe

Asia Pacific Japan China India Rest of Asia Pacific

Latin America

Middle East & Africa

Recent Developments:

In 2020, F.L. Medical SRL Launched VACUMED Tech blood collection sets with pre-attached holders

In 2020, BD had an agreement with Babson Diagnostics (US) To enable small-volume blood collection for diagnostic testing in retail settings

In 2020, Quest Diagnostics acquired Outreach Lab Businesses of Community Health Network and Ascension St. Vincent (US)

Frequently Asked Questions (FAQ):

What is theprojected market of the global blood collection devices market in 2025? The projected market of the global blood collection devices market is expected to be 6.4bilion in 2025. Who are the leading players in the blood collection devices market? Some of the leading players in the blood collection devices market include Becton, Dickinson and Company (US), ,Haematonics (US), Terumo BCT (Japan), Fresenius Kabi AG (Germany), Grifols (Spain) and Macopharma (France) Who are the major end-users of the blood collection devices market? The end user of the blood collection devices market includeshospitals, ASCs, & nursing homes, blood banks, diagnostic & pathology laboratories, and other end users.HospitalsASCs, & nursing homes are the largest end-users in the blood collection devices market. What are the major methods in the blood collection devicesmarket? By method, the global blood collection devices market is segmented into manual and automated blood collection. The manual blood collection segment is expected to dominate the global market. However, the automated blood collection segment is projected to register a higher CAGR during the forecast period. What are the major applications in the blood collection devices market? By application, the global blood collection devices market is segmented into diagnostics and therapeutics. The diagnostics segment is expected to dominate the blood collection devices market during the forecast period. .

To speak to our analyst for a discussion on the above findings, click Speak to Analyst